NCT02211417 - Oral DS107 in Moderate to Severe Atopic Dermatitis | Biotech Hunter

Enrollment

102

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

December 31, 2015

Conditions

Atopic Dermatitis

Interventions

DRUG

Oral DS107

DRUG

Placebo

Trial Locations (14)

Dignity Sciences investigational site, Arlington Heights

Dignity Sciences investigational site, West Dundee

Dignity Sciences investigational site, Warren

Dignity Sciences investigational site, Verona

Dignity Sciences investigational site, New York

Dignity Sciences investigational site, Rochester

Dignity Sciences investigational site, Hazleton

Dignity Sciences investigational site, Philadelphia

Dignity Sciences investigational site, Calgary

Dignity Sciences investigational site, Edmonton

Dignity Sciences investigational site, Markham

Dignity Sciences investigational site, Windsor

Dignity Sciences investigational site, Drummondville

Dignity Sciences investigational site, Montreal